Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 9

of 'Treatment of male sexual dysfunction'

Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion.
Sayuk GS, Gott BM, Nix BD, Lustman PJ
Diabetes Care. 2011 Feb;34(2):332-4.
OBJECTIVE: Major depressive disorder (MDD) and type 2 diabetes have independent adverse effects on sexual functioning (SF). Bupropion (BU) reportedly has few sexual side effects, but its use in diabetes has not been studied.
RESEARCH DESIGN AND METHODS: This article reports a planned secondary analysis of SF in 90 patients with type 2 diabetes treated with BU for MDD.
RESULTS: At baseline, 71.1% of patients had insufficient SF. Mean Sexual Energy Scale (SES) scores improved during treatment (P<0.0001), as did the percentage with sufficient SF (30.6 vs. 68.1%, P = 0.001). Patients with persistent hyperglycemia had higher rates of sexual dysfunction; however, SES improvement was evident in some with persistent depression or hyperglycemia (18.2% and 25.9%, respectively).
CONCLUSIONS: Insufficient SF is prevalent and may be suspected in patients with MDD and type 2 diabetes. BU treatment of MDD had few sexual side effects and was associated with significant improvements in SF.
Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.